Biofrontera AG Sponsored ADR Financing cash flow

Financing cash flow of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Financing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Financing cash flow for the quarter ending June 30, 2021 was $26.2 Million (a -2307.17% decrease compared to previous quarter)
  • Year-over-year quarterly Financing cash flow increased by 107.73%
  • Annual Financing cash flow for 2021 was $2.58 Million (a -70.31% decrease from previous year)
  • Annual Financing cash flow for 2021 was $8.7 Million (a 27.97% increase from previous year)
  • Annual Financing cash flow for 2020 was $6.79 Million (a -10.15% decrease from previous year)
  • Twelve month Financing cash flow ending June 30, 2021 was $63.4 Million (a 50.86% increase compared to previous quarter)
Trailing Financing cash flow for the last four month:
30 Jun '21 30 Jun '20 30 Sep '18
$63.4 Million $42.1 Million $67.5 Million
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Financing cash flow of Biofrontera AG Sponsored ADR

Most recent Financing cash flowof BFAGY including historical data for past 10 years.

Interactive Chart of Financing cash flow of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Financing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $26.22 $2.58
2020 $-1.19 $6.79
2019 $3.87
2018 $25.79 $26.31
2017 $12.62 $4.83 $10.68
2016 $24.21 $24.21

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic